alexa Bilateral Renal Masses with Different Histopathology Subtypes Treated byLaparoscopic Right Partial Nephrectomy and Bilateral Cryoablation-Results at 5 Years Follow-Up | Open Access Journals
Diagnostic Pathology: Open Access
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Bilateral Renal Masses with Different Histopathology Subtypes Treated byLaparoscopic Right Partial Nephrectomy and Bilateral Cryoablation-Results at 5 Years Follow-Up

Seguin Samuel1, Michel Carmel1, Claudio Jeldres1, Rabia Temmar2, Bui The Bao3 and Sabbagh Robert1*

1Department of Surgery, Urology Division, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Canada

2Department of Pathology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Canada

3Department of Radiology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrookebh, Canada

*Corresponding Author:
Sabbagh Robert
Associate Professor, Department of Surgery Urology
Division, Université de Sherbrooke Centre Hospitalier
Universitaire de Sherbrooke, Canada
Tel: (819) 346-1110 ext: 74595
Fax:
(819) 820-6411
E-mail: [email protected]

Received Date: October 02, 2015 Accepted Date: November 10, 2015 Published Date: November 15, 2015

Citation: Samuel S, Carmel M, Jeldres C, Temmar R, Bao BT, et al. (2015) Bilateral Renal Masses with Different Histopathology Subtypes Treated by Laparoscopic Right Partial Nephrectomy and Bilateral Cryoablation-Results at 5 Years Follow-Up. Diagn Pathol Open 1:101. doi: 10.4172/2476-2024.1000101

Copyright: © 2015 Samuel S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Diagnostic Pathology: Open Access

Abstract

We present the case of a 54 year old man with a synchronous mass on each kidney with different renal cell carcinoma (RCC) subtypes and a normal renal function. He categorically refused to undergo radical nephrectomy and open partial nephrectomies. He underwent a laparoscopic right partial nephrectomy and then percutaneous CTguided bilateral cryoablation. A second percutaneous CT-guided course of cryoablation on the right mass was performed at 6 months post cryoablation for recurrence. Both chest and abdomen CT-Scan at 60 months follow up did not reveal any local recurrence or distant metastasis.

Although cryoablation is a feasible treatment option for RCC, the authors do not recommend it as a first line therapy in an otherwise healthy patient with normal renal function.

Keywords

Type 1 papillary Renal Cell Carcinoma; Clear Cell Renal Carcinoma; Cryotherapy

Background

Surgical resection is considered the standard of care for clinically localized RCC [1]. Thermal ablative therapies, including renal cryoablation and radiofrequency ablation, have emerged as alternative nephron-sparing treatments for patients with localized RCC. Longterm efficacy is not well established as it is with surgery and preliminary data suggest that the local recurrence rates may be higher than those reported for traditional surgical approaches. However, distant metastases seem to be as prevalent as with conventional surgical techniques. The ideal candidates for ablative therapy for renal tumors are patients with advanced age or significant comorbidities who prefer a proactive approach but are not optimal candidates for conventional surgery or patients with local recurrence after previous nephron-sparing surgery [2].

Treatment of recurrent renal masses after a partial nephrectomy remains challenging. A second partial nephrectomy is not only technically more difficult but it may also be associated with higher risk of complications and a decrease in renal function [3,4,5]. In those specific cases, cryoablation may be an attractive alternative with minimal complications, renal function decrease and acceptable oncologic control [6].

Case Presentation

We report the case of a 54 year old healthy male referred for incidental bilateral solid renal masses. He was a former smoker and had no family history of renal disease. His renal function was normal with 96 μmol/L of serum creatinine. The CT-Scan performed for lower back ache revealed a 3.9 × 2.9 cm middle posterolateral mass mostly intrarenal and partially exophytic in the right kidney and a 2.8 × 2.4 cm hilar mass in the left kidney (Figure 1).

diagnostic-pathology-computed-tomography

Figure 1: Contrast enhanced computed tomography (CT) scans. Figure 1a: Right renal mass: An intrarenal and partially exophytic right renal mass located on the posterior side of the middle pole, measuring 3.9 × 2.9 cm. The lesion is heterogeneous, enhancing, without calcification or septation. There is no sign of extension. Figure 1b: Left renal mass: An oval lesion of 2.8 × 2.4 cm located in the left renal hilum, hypodense and homogeneous. It has a slight enhancement.

The left mass was biopsied because it was intrarenal and not amenable for a partial nephrectomy. The biopsy revealed a type 1 papillary RCC (Figure 2a). The patient categorically refused to undergo open partial or radical nephrectomy even unilateral. He finally accepted a laparoscopic right partial nephrectomy but unfortunately margins were positive. The pathology showed a clear cell RCC with Fuhrman grade II/IV which was a different histopathology subtype than the left renal mass (Figure 2b).

diagnostic-pathology-clear-cytoplasm

Figure 2: Microscopic examination of the left renal mass biopsy (HE staining; × 400). Specimen covered with cubic cells slightly cylindrical, a clear cytoplasm, whose nuclei have a slight pleomorphism with small visible nucleolus. The immunohistochemistry for the low molecular weight keratin, keratin 7 and the P504S is positive. It is negative for the keratin 20, chromogranin, protein S-100, and the APS TTF1. This is compatible with a Type 1 papillary renal cell carcinoma. Figure 2b: Microscopic examination of the right renal mass surgery specimen (HE staining; × 400). Histological type is a clear renal cell carcinoma.

Six months later a CT scan demonstrated a local recurrence with an enhancing core of 3 cm.

This case was fully discussed several times at tumor boards and with the patient but he repeatedly refused left radical nephrectomy or open right partial nephrectomy. In that special situation, percutaneous CTguided bilateral cryoablation for synchronous kidney cancer of different histology was performed to this young and otherwise healthy man. The two masses were treated with 3 cryoprobes equidistantly placed and a standard protocol of two 10 minutes freeze-thaw cycles. There were no complications. A CT scan performed at 6 month followup revealed a recurrence located on the right side showed by enhancement of the mass within the ablation zone (Figure 3).

diagnostic-pathology-first-cryoablation

Figure 3: Contrast enhanced computed tomography (CT) scans. Figure 3a: Right renal mass 6 months post first cryoablation. A 2.5 × 2.8 cm hypervascular and isodense mass to the cortex on the posterior side. It is consistent with a local recurrence post partial nephrectomy and cryoablation. Figure 3b: Left renal mass 6 months post second cryoablation. The left cryoablation area forms a crater with an hypodense necrotic area. The mass size reduced from 2.8 to 1.2 cm. There is no evidence of local recurrence.

The patient underwent a second percutaneous CT-guided cryoablation on the right side without prior biopsy since it would not change our management. We used the same protocol of two 10 minutes freeze-thaw cycles.

Five years after the laparoscopic right partial nephrectomy and subsequent bilateral cryoablation, there is no sign of recurrence on either side (Figure 4).

diagnostic-pathology-nephrectomy-bilateral

Figure 4: Contrast enhanced computed tomography (CT) scans 5 years after right partial nephrectomy and bilateral cryoablation. Figure 4a: Right side. Figure 4b: Left side. On each side there is a post-cryoablation scar area which is at the top of the right pole and at the middle of the left pole. This is consistent with scar remodeling, with no evidence of active tumor.

Discussion

Surgical therapy remains the mainstay of therapy to achieve a cure in the management of RCC. The 2013 European Association of Urology (EAU) guidelines on RCC recommend nephron-sparing surgery rather than radical nephrectomy whenever possible for patients with low-stage RCC (T1). Also, patients with small renal tumours and/or significant co-morbidity who are unfit for surgery should be considered for an ablative approach, e.g. cryoablation and radiofrequency ablation [1]. Cryoablation can also be considered as a safe and effective nephron-sparing alternative for treatment of local recurrence after partial nephrectomy [6]. In our case, the patient was fit for a right partial nephrectomy and a left radical nephrectomy but refused to undergo open surgery or radical nephrectomy. Because patient preference must also be considered, some patients who do not meet the above mentioned guidelines criteria may choose thermal ablation instead of surgery. This decision can be supported as long as balanced counseling about the current status on the different modalities has been provided to the patient [2].

There is poor literature about management of bilateral renal masses with cryoablation. There is a case report describing a patient with multiple bilateral chromophobe renal cell carcinoma treated successfully with laparoscopic partial nephrectomies and cryoablation with no recurrence at 3-month follow-up CT scan [7]. In a small serie of twenty patients only one patient was treated by cryotherapy for bilateral small renal masses. However, he refused follow up after 6 months where both masses were not visualized on imaging [8].

To our knowledge no literature addresses a possible link between the histologic renal cancer subtype and the clinical response to cryoablation.

Conclusion

The management of bilateral renal masses is technically challenging. This is the first case reported of synchronous bilateral renal masses with two different RCC subtypes treated with such an atypical management and a long follow-up. Bilateral cryoablation seems to be a viable treatment but the authors do not encourage this type of renal cancer treatment in an otherwise healthy patient as first line therapy. However they considered worth of reporting to the scientific community this case for future unusual situations where it could be a feasible option.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Journals

Article Usage

  • Total views: 7951
  • [From(publication date):
    March-2016 - Oct 23, 2017]
  • Breakdown by view type
  • HTML page views : 7907
  • PDF downloads :44

Review summary

  1. Kate Harper
    Posted on Aug 24 2016 at 3:01 pm
    The author discussed the clinical efficacy of cryoablation in the treatment of renal carcinomas. The author presented a case report of occurrence of renal cancer in a 54 years old man along with the histological subtypes as well as the application of cryoablation in the treatment procedure. The authors suggested that eventhough cryoablation is a feasible option for the first line of treatment but the reports of recurrence of the disease followed by cryoablation suggest that it should be avoided.
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords